Concepedia

Asprosin, a novel glucogenic adipokine: a potential therapeutic implication in diabetes mellitus

Munevver Gizem Hekım, Muhammed Mirac Keleştemur, Funda Gülcü Bulmuş, Ferah Bulut, Ebru Gökdere, Mehmet Ridvan Ozdede, Haluk Keleştimur, Sinan Canpolat, Mete Özcan

Archives of Physiology and Biochemistry · 2021 · 24 citations · 31 references

DOI

Abstract

Our novel findings implicate that asprosin may be a target molecule in preventing the development and complications of diabetes.

References

31

Positional cloning of the mouse obese gene and its human homologue

Yiying Zhang, Ricardo Proenca, Margherita Maffei et al. · Nature · 1994 · 13.3K citations

, , +10

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

Pouya Saeedi, Inga Petersohn, Belma Malanda et al. · Diabetes Research and Clinical Practice · 2019 · 10K citations

, , +8

Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans

Robert V. Considine, Madhur K. Sinha, Mark L. Heiman et al. · New England Journal of Medicine · 1996 · 6.3K citations

FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise

Joo Young Huh, Grigorios Panagiotou, Vassilis Mougios et al. · Metabolism · 2012 · 1K citations · Full text

, , +9

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

José María Moreno‐Navarrete, Francisco Ortega, Marta Serrano et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 787 citations